Friday, November 15, 2024
HomeIndustriesHealthcare

Healthcare

Novo Nordisk announces impact from Volume Based Procurement for insulin in China

Novo Nordisk announced that the company has received the results from the Volume Based Procurement (VBP) tender for insulin in China. The Chinese National...

One step closer to interoperability: Applying SNOMED CT’s engine to the International Patient Summary

At SNOMED International’s recent October Business Meetings held in London, the organization’s governance bodies enacted a decision to extend the core of SNOMED CT’s...

Gynov SAS announces investment from eureKARE SA

Gynov ("the Company"), a French company that designs, manufactures and markets innovative nutritional supplements, Food for Special Medical Purposes (DADFMS) and medical devices for...

Leronlimab (350 mg) Weekly Use for 14 Weeks in Open Label Arm of NASH Trial Produces Fibrosis Reduction as High as 93 msec Amongst...

CytoDyn Inc., a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, reported data from its trial treating...

54% of Europeans Consider Their Current Physical Health to Be Good or Very Good, as Survey Reveals Public Perceptions of Health Following Nearly Two...

After two years of the Covid-19 pandemic, results from a European survey reveal that more than half of Europeans rate their physical health as...
0FansLike
0FollowersFollow
spot_img

Hot Topics